收费全文 | 8095篇 |
免费 | 493篇 |
国内免费 | 41篇 |
耳鼻咽喉 | 146篇 |
儿科学 | 269篇 |
妇产科学 | 152篇 |
基础医学 | 1052篇 |
口腔科学 | 219篇 |
临床医学 | 636篇 |
内科学 | 2137篇 |
皮肤病学 | 93篇 |
神经病学 | 916篇 |
特种医学 | 360篇 |
外科学 | 1073篇 |
综合类 | 34篇 |
一般理论 | 9篇 |
预防医学 | 490篇 |
眼科学 | 159篇 |
药学 | 423篇 |
中国医学 | 17篇 |
肿瘤学 | 444篇 |
2024年 | 11篇 |
2023年 | 73篇 |
2022年 | 217篇 |
2021年 | 383篇 |
2020年 | 216篇 |
2019年 | 304篇 |
2018年 | 349篇 |
2017年 | 237篇 |
2016年 | 237篇 |
2015年 | 300篇 |
2014年 | 375篇 |
2013年 | 437篇 |
2012年 | 674篇 |
2011年 | 674篇 |
2010年 | 354篇 |
2009年 | 303篇 |
2008年 | 527篇 |
2007年 | 465篇 |
2006年 | 406篇 |
2005年 | 450篇 |
2004年 | 392篇 |
2003年 | 289篇 |
2002年 | 267篇 |
2001年 | 86篇 |
2000年 | 74篇 |
1999年 | 63篇 |
1998年 | 51篇 |
1997年 | 46篇 |
1996年 | 33篇 |
1995年 | 31篇 |
1994年 | 29篇 |
1993年 | 22篇 |
1992年 | 33篇 |
1991年 | 28篇 |
1990年 | 21篇 |
1989年 | 19篇 |
1988年 | 16篇 |
1987年 | 18篇 |
1986年 | 17篇 |
1985年 | 17篇 |
1984年 | 8篇 |
1983年 | 8篇 |
1982年 | 6篇 |
1981年 | 10篇 |
1979年 | 6篇 |
1978年 | 5篇 |
1977年 | 6篇 |
1969年 | 4篇 |
1968年 | 4篇 |
1967年 | 4篇 |
Introduction
The fast track / ultra-fast-track protocols are techniques used to optimise the patient care process and a quick recovery after cardiac surgery. They are one of the mainstays of efficient practice. With their use, the length of hospital and intensive care unit (ICU) stays are reduced, with a direct impact on costs and the quality of the health service.Objective
To compare the length of stay in the ICU, length of hospital stay, and post-operative mortality in ultra-fast-track extubated (uFTE) patients and those with conventional extubation (CE) after cardiac surgery.Methods
Longitudinal, analytical, retrospective study was conducted, with the period between the time of surgery and discharge being included as the study period.Results
A total of 396 patients older than 18 years who required cardiac surgery were included, of whom 207 patients had (uFTE) and 189 had CE. Although the groups were not comparable due to the statistical differences found, when performing the multivariate adjustment, uFTE maintained its statistical independence and was associated with lower cardiovascular morbidity, such as myocardial ischaemia (95% CI: 0.37-0.86; P = .01) and lower post-surgical vasopressor requirement (95% CI: 0.18-0.49; P < .01). No significant differences were found in the length of hospital stay, ICU stay, or post-operative mortality in the ICU.Conclusion
Implementing the uFTE strategy, decreases cardiovascular morbidity and vasopressor requirement. The change to uFTE should be accompanied by changes in models and practices in patient recovery to standardised protocols. This study shows that uFTE did not reduce the length of ICU stay, hospital stay, or mortality. 相似文献Areas covered: This review first focuses on the clinical trials evaluating the efficacy and tolerability of nab-paclitaxel in NSCLC at different settings. The approval of nab-paclitaxel in combination with carboplatin at the front-line setting for advanced NSCLC was based on the key phase III study, which showed that nab-paclitaxel/carboplatin was associated with superior overall response rate and favorable toxicity profile compared to sb-paclitaxel/carboplatin. The review also addresses the nab-paclitaxel pharmacology, other combinations (e.g. immunotherapy with PD-1/PD-L1 inhibitors), potential biomarkers (e.g. caveolin-1), and special subgroups (e.g. the elderly, squamous histology).
Expert opinion: Existing data has established the role of nab-paclitaxel in the management of advanced NSCLC. Emerging evidence, such as preliminary results from Keynote-407 and IMpower 131 studies, indicates that novel combinations of nab-paclitaxel/carboplatin and PD-1/PD-L1 inhibitors could further improve clinical benefits with manageable toxicity. Nevertheless, in order to better position nab-paclitaxel and to improve patient selection, future studies are warranted to further understand its mechanism of action, predictive biomarkers, and potential synergism with other agents. 相似文献